Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;46(3):226-32.
doi: 10.2478/v10019-012-0035-x. Epub 2012 Jun 19.

The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model

Affiliations

The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model

Elham Raeisi et al. Radiol Oncol. 2012 Sep.

Abstract

Background: The aim of this study was to investigate the antitumor effectiveness of electrochemotherapy with cisplatin combined with suboptimal radiotherapy doses. Tumor radiosensitization was evaluated on large invasive ductal carcinoma tumors in Balb/C mice.

Materials and methods: Tumors of an average volume of 630 mm(3) were treated with cisplatin, electric pulses, radiotherapy, electrochemotherapy, alone as well as in appropriate combinations. Tumors were irradiated with Cobalt-60 γ-rays at doses 3 Gy and 5 Gy in combination with electrochemotherapy using cisplatin. Controls included each of the treatments alone as well as the combination of the radiotherapy with electric pulses alone or with cisplatin alone. Antitumor effectiveness was evaluated by tumor growth delay, tumor-doubling time, inhibition ratio and the objective response rates.

Results: As anticipated, electrochemotherapy was more effective than the treatment with cisplatin alone or the application of the electric pulses alone. When treatments were combined with tumor irradiation at either 3 or 5 Gy, the combination with electrochemotherapy was more effective: at 5 Gy, 2 animals out of 8 were in complete remission 100 days later. In general the higher 5 Gy dose of γ-radiation was more effective than the lower one of 3 Gy.

Conclusions: The results of our study demonstrate that irradiation doses, 3 Gy or 5 Gy, increase the antitumor effectiveness of electrochemotherapy with cisplatin on invasive ductal carcinoma tumors. Good antitumor results were achieved in experimental tumors with a size comparable to clinical lesions, demonstrating that this three-modality combined treatment is useful for the treatment of large lesions even at sub-optimal radiotherapy doses.

Keywords: cisplatin; electroporation; invasive ductal carcinoma; irradiation; multimodalities.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Tumor growth curves in untreated tumors or after treatment with CDDP (CDDP), electric pulses (EP) only, irradiation (IR) only, electrochemotherapy (ECT) and the combinations of CDDP or electric pulses and radiotherapy. Data are mean ± SE of at least 8 animals for each of the experimental groups. Irradiation of tumor was 3Gy.
FIGURE 2
FIGURE 2
Tumor growth curves for invasive ductal carcinoma tumors after treatment with radiotherapy (IR) only, electrochemotherapy (ECT), combination of CDDP or electric pulses and radiotherapy at dose of 3 Gy in comparison to 5 Gy. Data are mean ± SE of at least 8 animals for each of the experimental groups.
FIGURE 3
FIGURE 3
Individual tumor growth curves of tumors treated by the combination of electrochemotherapy (ECT) and radiotherapy at the dose of 5 Gy.

References

    1. Gately DP, Howell SB. Cellular accumulation of the anticancer agent CDDP: a review. Br J Cancer. 1993;67:1171–6. - PMC - PubMed
    1. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573–84. - PubMed
    1. Lekic M, Kovac V, Triller N, Knez L, Sadikov A, Cufer T. Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting. Radiol Oncol. 2012;46(3):226–232. 46: 54–9. - PMC - PubMed
    1. Malecki K, Glinski B, Mucha-Malecka A, Rys J, Kruczak A, Roszkowski K, et al. Prognostic and predictive significance of p53, EGFr, Ki-67 in larynx preservation treatment. Rep Pract Oncol Radiother. 2010;15:87–92. - PMC - PubMed
    1. Kovac V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Neoplasma. 2004;51:334–40. - PubMed